| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
QMed, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -99.90% |
| 5 Year Change | -99.00% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| QMED | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -0.8% | 2.9% |
| 1Y | n/a | 1.7% | 22.2% |
Return vs Industry: Insufficient data to determine how QMED performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how QMED performed against the US Market.
Price Volatility
| QMED volatility | |
|---|---|
| QMED Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: QMED has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine QMED's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | n/a | Jane Murray | www.qmedinc.com |
QMed, Inc. does not have significant operations. Previously, the company was engaged in providing disease management services to health plans and federal government. QMed, Inc. was founded in 1983 and is based in Eatontown, New Jersey.
QMed, Inc. Fundamentals Summary
| QMED fundamental statistics | |
|---|---|
| Market cap | US$17.00 |
| Earnings (TTM) | -US$6.72m |
| Revenue (TTM) | US$4.27m |
0.0x
P/S Ratio0.0x
P/E RatioIs QMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QMED income statement (TTM) | |
|---|---|
| Revenue | US$4.27m |
| Cost of Revenue | US$2.34m |
| Gross Profit | US$1.93m |
| Other Expenses | US$8.65m |
| Earnings | -US$6.72m |
Last Reported Earnings
Feb 29, 2008
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did QMED perform over the long term?
See historical performance and comparison